Skip to main content

Advertisement

Table 3 Factors that influence thromboembolic events by stepwise logistic regression method

From: Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

Factor Adjusted ODDS ratio 95% CI P-value
Very low-dose (75 mg twice daily) 6.88 1.67–28.3 0.008*
H: Hypertension 2.25 0.83–6.12 0.110
A: Aged 75 or older 2.76 0.92–8.23 0.068
S: Stroke/TIA 2.97 1.11–7.94 0.030*
  1. *P < 0.05